A new algorithm enables smartwatch fitness trackers to more accurately monitor energy expenditure of people with obesity ...

But it’s taking neither seriously. Despite the fact that more than 64% of people in the UK are either overweight or obese our ...

Amidst the global rise in obesity, Hons (Dr) Saurabh Kaushik guides audiences at AMA on eating right, staying disciplined and ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Staying hydrated is crucial to feeling your best, especially as temperatures across the globe soar. Some may turn to powdered ...

A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Ascletis Pharma has dosed the first obese or overweight subjects in the 13-week, multi-centre US Phase IIa trial of ASC30.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

For adults with overweight or obesity, time-restricted eating (TRE) does not lead to significant changes in sleep, mood, or ...

Obesity is independently associated with financial hardship and food insecurity, according to recent research.

Prime Minister Sir Keir Starmer has unveiled the government’s plan to “fundamentally rewire” the NHS in England. While the ...